Skip to main content
. 2016 Dec 12;6:257. doi: 10.3389/fonc.2016.00257

Table 1.

Stage-dependent alterations in cancer cell metabolism.

Cause Effect Potential treatment
Intrinsic (Warburg) P53-deficient tumor cells do not have functional SCO2 or TIGAR and display a glycolytic metabolism phenotype Protect from apoptosis by closing Kv channels and preventing the influx of calcium Dichloroacetate, lonidamine
Embryonic M2 isoform of pyruvate kinase shifts cellular metabolism to aerobic glycolysis Satisfaction of anabolic requirements, biosynthetic activities by proliferating tumor cells entail the production of ribose-5-phosphate for nucleotide biosynthesis, and the production of fatty acids for lipid biosynthesis

Deadhesion Deadherent cells suffer deficit in glucose transport, resulting in adenosine triphosphate (ATP) deficiency and anoikis Peroxide signaling, increased mitochondrial activity Anti-oxidants
Serine–glycine–creatine pathway regenerates ATP

Stromal interaction Lactate secretion from mesenchymal cells via the transporter MCT4 Tumor cells import this lactate via MCT1 expression, converting it to pyruvate and introducing it into the Krebs cycle, resulting increased in oxidative phosphorylation and ATP production

Hypoxia Hypoxia, low-glucose, lactate Induction of HIF-1, carbonic anhydrase IX Methazolamide